Vulnerability in Pharmaguideline
CVE-2014-6721
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
Published · last modified .
CVSS v2 metric
CVSS v2 base score 5.4 (Medium). Vector: AV:A/AC:M/Au:N/C:P/I:P/A:P. This CVE predates CVSS v3 and has no v3 score from NVD.
EPSS exploit prediction
EPSS 0.007, 52.1th percentile (last changed ); unchanged over 30 days. About EPSS.
Affected products
- Pharmaguideline — versions 1.2.0
Weakness classification (CWE)
Public exploits and proof-of-concept code
1 public repository with exploit or proof-of-concept code for this CVE:
- sagisar1/CVE-2014-6721-exploit-Shellshock (last pushed 2024-03-17): exploit of the Shellshock vulnerability
Also mentioned in 1 other repository (team4kira/Cybersecurity-Project-2). These reference the CVE in a list, notes or a scanner and are not exploit code for it.
References
- VU#819305 (US Government Resource, third-party-advisory)
- VU#582497 (US Government Resource, third-party-advisory)
- docs.google.com/spreadsheets/d/1t5GXwjw82SyunALVJb2w0zi3FoLRIkfGPc7AMjRF0r4/edit
This CVE has public exploit evidence. See the latest CVEs with public exploits.